Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, May 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 353 articles:
HTML format


 

Single Articles

  1. THE LANCET ONCOLOGY
    Cervical cancer screening and New Zealand's uncomfortable truths.
    Lancet Oncol. 2021;22:571.
    PubMed    


  2. ALI SM, Clark MT, Khedher Ghalib A, Skirton H, et al
    "We don't have up to date knowledge about the disease" Practical challenges encountered in delivery of cervical cancer screening in Iraq.
    Eur J Cancer Care (Engl). 2021 May 1:e13457. doi: 10.1111/ecc.13457.
    PubMed    
    Abstract available


  3. Tisotumab Vedotin Yields Responses as Second-Line Cervical Cancer Therapy.
    Cancer Discov. 2021 Apr 30. pii: 2159-8290.CD-RW2021.
    PubMed    
    Abstract available

  4. LI L, Gong Y, Xu K, Chen W, et al
    ZBTB28 induces autophagy by regulation of FIP200 and Bcl-XL facilitating cervical cancer cell apoptosis.
    J Exp Clin Cancer Res. 2021;40:150.
    PubMed    
    Abstract available

  5. SONG F, Yan P, Huang X, Wang C, et al
    Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China.
    BMC Infect Dis. 2021;21:400.
    PubMed    
    Abstract available

  6. MUHIMPUNDU MA, Ngabo F, Sayinzoga F, Balinda JP, et al
    Screen, Notify, See, and Treat: Initial Results of Cervical Cancer Screening and Treatment in Rwanda.
    JCO Glob Oncol. 2021;7:632-638.
    PubMed    
    Abstract available

  7. SEPPENWOOLDE Y, Majercakova K, Buschmann M, Dorr E, et al
    Early morbidity and dose-volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques.
    Strahlenther Onkol. 2021 Apr 30. pii: 10.1007/s00066-021-01781.
    PubMed    
    Abstract available

  8. HU YL, Zhang YX, Liu N, Liu H, et al
    LncRNA MIR503HG regulated cell viability, metastasis and apoptosis of cervical cancer via miR-191/CEBPB axis.
    Eur Rev Med Pharmacol Sci. 2021;25:3200-3210.
    PubMed    
    Abstract available

  9. WEI H, He WR, Chen KM, Wang XW, et al
    MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2.
    Eur Rev Med Pharmacol Sci. 2021;25:3147.
    PubMed    
    Abstract available

  10. SUN X, Xu H, Dai T, Xie L, et al
    Alantolactone inhibits cervical cancer progression by downregulating BMI1.
    Sci Rep. 2021;11:9251.
    PubMed    
    Abstract available

  11. ACUTI MARTELLUCCI C, Morettini M, Flacco ME, Manzoli L, et al
    Delivering cervical cancer screening during the COVID-19 emergency.
    BMJ Sex Reprod Health. 2021 Apr 29. pii: bmjsrh-2021-201099.
    PubMed    


  12. SARWAR A, Lalli N, Aughwane P, Eminowicz G, et al
    Feasibility of ureter delineation and dose recording in the assessment of ureteric stenosis during brachytherapy for cervical cancer.
    Brachytherapy. 2021 Apr 26. pii: S1538-4721(21)00056.
    PubMed    
    Abstract available

  13. LIU K, Xue B, Bai G, Zhang W, et al
    Downregulation of Diacylglycerol kinase zeta (DGKZ) suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest.
    Bioengineered. 2021;12:1517-1529.
    PubMed    
    Abstract available

  14. TANEJA N, Chawla B, Awasthi AA, Shrivastav KD, et al
    Knowledge, Attitude, and Practice on Cervical Cancer and Screening Among Women in India: A Review.
    Cancer Control. 2021;28:10732748211010799.
    PubMed    
    Abstract available

  15. CHUA B, Ma V, Asjes C, Lim A, et al
    Barriers to and Facilitators of Cervical Cancer Screening among Women in Southeast Asia: A Systematic Review.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  16. IJFF M, van Bochove GGW, Whitton D, Winiarczyk R, et al
    PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  17. DURANTI S, Pietragalla A, Daniele G, Nero C, et al
    Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  18. CHIZENGA EP, Abrahamse H
    Biological Therapy with Complementary and Alternative Medicine in Innocuous Integrative Oncology: A Case of Cervical Cancer.
    Pharmaceutics. 2021;13.
    PubMed    
    Abstract available

  19. GOLUBICKAITE I, Ugenskiene R, Ziliene E, Beniusyte J, et al
    POLG Gene Variants in Cervical Cancer Patients and Their Associations with Clinical and Pathomorphological Tumor Characteristics.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  20. HOREWEG N, Mittal P, Gradowska PL, Boere I, et al
    Adjuvant Systemic Therapy after Chemoradiation and Brachytherapy for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  21. CIESLAK M, Napiorkowska M, Kazmierczak-Baranska J, Krolewska-Golinska K, et al
    New Succinimides with Potent Anticancer Activity: Synthesis, Activation of Stress Signaling Pathways and Characterization of Apoptosis in Leukemia and Cervical Cancer Cells.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  22. RAHMAN A, Kobayashi M, Sugimoto K, Endo Y, et al
    Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  23. DAPONTE A, Michail G, Daponte AI, Daponte N, et al
    Urine HPV in the Context of Genital and Cervical Cancer Screening-An Update of Current Literature.
    Cancers (Basel). 2021;13.
    PubMed    
    Abstract available

  24. ANDIKYAN V, Griffith M, Tymon-Rosario J, Momeni M, et al
    Variability in the identification of lymphovascular space invasion for early stage cervical cancer.
    Surg Oncol. 2021;38:101566.
    PubMed    
    Abstract available

  25. PALSDOTTIR K, Fridsten S, Blomqvist L, Alagic Z, et al
    Inter-observer agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer.
    Ultrasound Obstet Gynecol. 2021 Apr 29. doi: 10.1002/uog.23662.
    PubMed    
    Abstract available

  26. BODZEK P, Szymala B, Damasiewicz-Bodzek A, Janosz I, et al
    Are IgG antibodies to heat shock proteins HSP27 and HSP60 useful markers in endometrial cancer and cervical cancer?
    Ginekol Pol. 2021 Apr 29. pii: VM/OJS/J/74295. doi: 10.5603/GP.a2021.0060.
    PubMed    
    Abstract available

  27. WRIGHT JD, Chen L, Tergas AI, Melamed A, et al
    Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.
    JAMA Netw Open. 2021;4:e218373.
    PubMed    
    Abstract available

  28. DANG L, Qiao Y, Lang J
    High-risk Human Papillomavirus Testing for Cervical Cancer Screening-Reply.
    JAMA Oncol. 2021 Apr 29. pii: 2778917. doi: 10.1001/jamaoncol.2021.0738.
    PubMed    


  29. TOTTEN SPS, Romero JM
    High-risk Human Papillomavirus Testing for Cervical Cancer Screening.
    JAMA Oncol. 2021 Apr 29. pii: 2778919. doi: 10.1001/jamaoncol.2021.0735.
    PubMed    


  30. LEWICKI PJ, Basourakos SP, Qiu Y, Hu JC, et al
    Effect of a Randomized, Controlled Trial on Surgery for Cervical Cancer.
    N Engl J Med. 2021;384:1669-1671.
    PubMed    


  31. GORCHEV GA, Tomov ST, Kiprova DK, Lyubenov AD, et al
    Analysis of abdominal vs. robotic radical hysterectomies for patients with cervical cancer: a Bulgarian experience.
    J Robot Surg. 2021 Apr 28. pii: 10.1007/s11701-021-01244.
    PubMed    
    Abstract available

  32. BAI L, Ma Y, Wang X, Feng Q, et al
    Polydatin Inhibits Cell Viability, Migration, and Invasion Through Suppressing the c-Myc Expression in Human Cervical Cancer.
    Front Cell Dev Biol. 2021;9:587218.
    PubMed    
    Abstract available

  33. MUREWANHEMA G
    Reduced cervical cancer screening in Zimbabwe as an indirect impact of the COVID-19 pandemic: implications for prevention.
    Pan Afr Med J. 2021;38:131.
    PubMed    
    Abstract available

  34. KAKANI P, Kojima N, Banda BA, Lewis S, et al
    Increasing cervical cancer screening at a non-government medical center in Lilongwe, Malawi.
    Int J STD AIDS. 2021 Apr 28:9564624211007260. doi: 10.1177/09564624211007260.
    PubMed    
    Abstract available

  35. BUJNAK AC, Tewari KS
    Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
    J Gynecol Oncol. 2021 Apr 19. pii: 32.e62. doi: 10.3802/jgo.2021.
    PubMed    


  36. LI X, Zhao J, Yan T, Mu J, et al
    Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
    J Food Sci. 2021 Apr 28. doi: 10.1111/1750-3841.15740.
    PubMed    
    Abstract available

  37. ONAL C, Oymak E, Guler OC
    Long-term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.
    Clin Oncol (R Coll Radiol). 2021 Apr 24. pii: S0936-6555(21)00147.
    PubMed    


  38. TAPERA O, Dreyer G, Nyakabau AM, Kadzatsa W, et al
    Model strategies to address barriers to cervical cancer treatment and palliative care among women in Zimbabwe: a public health approach.
    BMC Womens Health. 2021;21:180.
    PubMed    
    Abstract available

  39. IGISSINOV N, Igissinova G, Telmanova Z, Bilyalova Z, et al
    New Trends of Cervical Cancer Incidence in Kazakhstan.
    Asian Pac J Cancer Prev. 2021;22:1295-1304.
    PubMed    
    Abstract available

  40. AZIMI T, Paryan M, Mondanizadeh M, Sarmadian H, et al
    Pap Smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer.
    Asian Pac J Cancer Prev. 2021;22:1271-1277.
    PubMed    
    Abstract available

  41. NOEGROHO BS, Kurniawan AP, Wijayanti Z, Mustafa A, et al
    Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
    Asian Pac J Cancer Prev. 2021;22:1211-1216.
    PubMed    
    Abstract available

  42. SABEENA S, Ravishankar N
    Role of microRNAs in Predicting the Prognosis of Cervical Cancer Cases: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2021;22:999-1006.
    PubMed    
    Abstract available

  43. MADALENA RIBEIRO C, Dos Santos Silva I, Eluf Neto J, Pereira Baltar Cury LC, et al
    Follow-up of women screened for cervical cancer in Sao Paulo, Brazil: An analysis of the times to diagnostic investigation and treatment.
    Cancer Epidemiol. 2021;72:101940.
    PubMed    
    Abstract available

  44. SHI J, Ding X, Liu X, Li Y, et al
    Automatic Clinical Target Volume Delineation for Cervical Cancer in CT Images Using Deep Learning.
    Med Phys. 2021 Apr 27. doi: 10.1002/mp.14898.
    PubMed    
    Abstract available

  45. YANG XL, Wang MM, Kou LN, Lai H, et al
    Conditional survival for high-risk early-stage cervical cancer patients with lymph node metastasis after hysterectomy.
    Curr Probl Cancer. 2021 Apr 18:100756.
    PubMed    
    Abstract available

  46. LI T, Huang H, Hu Y, Chen H, et al
    Rs2686344 and serum squamous cell carcinoma antigen could predict clinical efficacy of neoadjuvant chemotherapy for cervical cancer.
    Curr Probl Cancer. 2021 Apr 18:100755.
    PubMed    
    Abstract available

  47. IBANEZ R, Mareque M, Granados R, Andia D, et al
    Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain.
    BMC Womens Health. 2021;21:178.
    PubMed    
    Abstract available


  48. [A case of isolated skull recurrence of cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2021;56:289-291.
    PubMed    


  49. GUO CL, Luo HX, Wang C, Qu XF, et al
    [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
    Zhonghua Fu Chan Ke Za Zhi. 2021;56:271-279.
    PubMed    
    Abstract available

  50. ARGEFA TG, Roets L
    Malnutrition and the Survival of Cervical Cancer Patients: A Prospective Cohort Study Using the PG-SGA Tool.
    Nutr Cancer. 2021 Apr 24:1-9. doi: 10.1080/01635581.2021.1910320.
    PubMed    
    Abstract available

  51. NIYOTEKA S, Berger T, Fokdal LU, Petersen JBB, et al
    Impact of interfractional target motion in locally advanced cervical cancer patients treated with spot scanning proton therapy using an internal target volume strategy.
    Phys Imaging Radiat Oncol. 2021;17:84-90.
    PubMed    
    Abstract available

  52. ZHANG J, Jiang P, Wang S, Cheng W, et al
    LncRNA LIPE-AS1 Predicts Poor Survival of Cervical Cancer and Promotes Its Proliferation and Migration via Modulating miR-195-5p/MAPK Pathway.
    Front Oncol. 2021;11:639980.
    PubMed    
    Abstract available

  53. BAYRAK M, Abakay CD
    Prevention of uterine perforation during intracavitary brachytherapy of cervical cancer.
    J Contemp Brachytherapy. 2021;13:167-171.
    PubMed    
    Abstract available

  54. RIVERA A, Wassel M, Brodin PN, Yaparpalvi R, et al
    Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes.
    J Contemp Brachytherapy. 2021;13:158-166.
    PubMed    
    Abstract available

  55. LIN AJ
    In Reply to Onal et al. Long-term Outcomes of Cervical Cancer Patients Treated with Definitive Chemoradiation Following a Complete Metabolic Response.
    Clin Oncol (R Coll Radiol). 2021 Apr 21. pii: S0936-6555(21)00149.
    PubMed    


  56. BIZZARRI N, Pedone Anchora L, Kucukmetin A, Ratnavelu N, et al
    Risk of ovarian recurrence after ovarian conservation in early-stage cervical cancer treated with radical surgery: A propensity match analysis.
    Eur J Surg Oncol. 2021 Apr 14. pii: S0748-7983(21)00414.
    PubMed    
    Abstract available

  57. KENARI AJ, Siadati SN, Abedian Z, Sohbatzadeh F, et al
    Therapeutic effect of cold atmospheric plasma and its combination with radiation as a novel approach on inhibiting cervical cancer cell growth (HeLa cells).
    Bioorg Chem. 2021;111:104892.
    PubMed    
    Abstract available

  58. BELFORT IKP, Cunha APA, Mendes FPB, Galvao-Moreira LV, et al
    Trichomonas vaginalis as a risk factor for human papillomavirus: a study with women undergoing cervical cancer screening in a northeast region of Brazil.
    BMC Womens Health. 2021;21:174.
    PubMed    
    Abstract available

  59. VOLPINI LPB, Dias JA, de Freitas LB, Silva MCLF, et al
    Viral load and high prevalence of HR-HPV52 and 58 types in black women from rural communities.
    BMC Infect Dis. 2021;21:362.
    PubMed    
    Abstract available

  60. BENSEN R, Brognard J
    New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  61. JAENKE R, Butler TL, Condon J, Garvey G, et al
    Health care provider perspectives on cervical screening for Aboriginal and Torres Strait Islander women: a qualitative study.
    Aust N Z J Public Health. 2021;45:150-157.
    PubMed    
    Abstract available

  62. KARADZA M, Zidovec Lepej S, Planinic A, Grgic I, et al
    Distribution of human papillomavirus genotypes in women with high-grade cervical intraepithelial lesions and cervical carcinoma and analysis of human papillomavirus-16 genomic variants.
    Croat Med J. 2021;62:68-79.
    PubMed    
    Abstract available

  63. HOLLOWAY SB, Colon GR, Zheng W, Lea JS, et al
    Tumor Necrotic Debris and High Nuclear Grade: Newly Identified High-risk Factors for Early-stage Endocervical Adenocarcinoma.
    Am J Clin Oncol. 2021;44:162-168.
    PubMed    
    Abstract available

  64. WU Y, Zhang Y, Chen X, Hu Y, et al
    A theranostic probe of indoleamine 2,3-dioxygenase 1 (IDO1) for small molecule cancer immunotherapy.
    Eur J Med Chem. 2021;213:113163.
    PubMed    
    Abstract available

  65. LUNA AJ, Sterk RT, Griego-Fisher AM, Chung JY, et al
    MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors.
    PLoS Pathog. 2021;17:e1009216.
    PubMed    
    Abstract available

  66. WANG X, Song J, Zhou S, Lu Y, et al
    A comparative study of methods for determining Intravoxel incoherent motion parameters in cervix cancer.
    Cancer Imaging. 2021;21:12.
    PubMed    
    Abstract available

  67. LI M, Liu T, Luo G, Sun X, et al
    Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007-2018: A retrospective cohort study.
    J Infect Public Health. 2021;14:42-49.
    PubMed    
    Abstract available

  68. MAJED L, Bresse X, El Mouaddin N, Schmidt A, et al
    Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France.
    Vaccine. 2020 Nov 28. pii: S0264-410X(20)31420.
    PubMed    
    Abstract available

  69. HU S, Xu X, Zhang Y, Liu Y, et al
    A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31469.
    PubMed    
    Abstract available

  70. ZHU S, Chang J, Hayat K, Li P, et al
    Parental preferences for HPV vaccination in junior middle school girls in China: A discrete choice experiment.
    Vaccine. 2020 Nov 19. pii: S0264-410X(20)31460.
    PubMed    
    Abstract available

  71. WANG Q, Zhang W, Cai H, Cao Y, et al
    Understanding the perceptions of Chinese women of the commercially available domestic and imported HPV vaccine: A semantic network analysis.
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31442.
    PubMed    
    Abstract available

  72. MURALL CL, Reyne B, Selinger C, Bernat C, et al
    HPV cervical infections and serological status in vaccinated and unvaccinated women.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31398.
    PubMed    
    Abstract available

  73. CHESSON HW, Meites E, Ekwueme DU, Saraiya M, et al
    Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31312.
    PubMed    
    Abstract available

  74. BEYER WEP, Osterhaus ADME
    Bivalent AS04-adjuvanted HPV vaccine provides optimal cancer prevention for HPV types not included in the vaccine.
    Vaccine. 2020 Oct 10. pii: S0264-410X(20)31157.
    PubMed    
    Abstract available

  75. AUDREY S, Farr M, Roderick M, Evans K, et al
    How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31256.
    PubMed    
    Abstract available

  76. LACK A, Hiligsmann M, Bloem P, Tunnessen M, et al
    Parent, provider and vaccinee preferences for HPV vaccination: A systematic review of discrete choice experiments.
    Vaccine. 2020 Oct 3. pii: S0264-410X(20)31133.
    PubMed    
    Abstract available

  77. JENTSCHKE M, Kampers J, Becker J, Sibbertsen P, et al
    Prophylactic HPV vaccination after conization: A systematic review and meta-analysis.
    Vaccine. 2020 Aug 4. pii: S0264-410X(20)30986.
    PubMed    
    Abstract available

  78. CORNALL AM, Saville M, Pyman J, Callegari ET, et al
    HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
    Vaccine. 2020 Jul 28. pii: S0264-410X(20)30955.
    PubMed    
    Abstract available

  79. CHEN Q, Zhao H, Yao X, Lin Z, et al
    Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages.
    Vaccine. 2020 Jul 24. pii: S0264-410X(20)30948.
    PubMed    
    Abstract available

  80. PEDERSEN EA, Loft LH, Jacobsen SU, Soborg B, et al
    Strategic health communication on social media: Insights from a Danish social media campaign to address HPV vaccination hesitancy.
    Vaccine. 2020 May 29. pii: S0264-410X(20)30706.
    PubMed    
    Abstract available

  81. QIN S, Fu JX, Chen MZ, Meng YT, et al
    Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: A cross-sectional study.
    Vaccine. 2020 May 26. pii: S0264-410X(20)30635.
    PubMed    
    Abstract available

  82. SIMONS JJM, Vida N, Westra TA, Postma MJ, et al
    Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands.
    Vaccine. 2020 May 22. pii: S0264-410X(20)30661.
    PubMed    
    Abstract available

  83. SILVERBERG MJ, Leyden WA, Lam JO, Chao CR, et al
    Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women.
    Vaccine. 2020 May 20. pii: S0264-410X(20)30610.
    PubMed    
    Abstract available

  84. BATMUNKH T, Dalmau MT, Munkhsaikhan ME, Khorolsuren T, et al
    A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Vaccine. 2020 May 6. pii: S0264-410X(20)30534.
    PubMed    
    Abstract available

  85. ATEMNKENG N, Aji AD, de Sanjose S, Mayaud P, et al
    Antiretroviral therapy and detection of high-grade cervical intraepithelial neoplasia (CIN2+) at post-CIN management follow-up among women living with HIV: a systematic review and meta-analysis.
    Clin Infect Dis. 2020 Mar 11. pii: 5803381. doi: 10.1093.
    PubMed    
    Abstract available

  86. TOTA JE, Struyf F, Sampson JN, Gonzalez P, et al
    Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials.
    J Natl Cancer Inst. 2019 Nov 7. pii: 5614431. doi: 10.1093.
    PubMed    
    Abstract available

  87. SOMEYA M, Tsuchiya T, Fukushima Y, Hasegawa T, et al
    Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy.
    Med Mol Morphol. 2021 May 8. pii: 10.1007/s00795-021-00290.
    PubMed    
    Abstract available

  88. ARMBRUST R, Chen F, Richter R, Muallem MZ, et al
    Results of a German wide survey towards current surgical approach in early stage cervical cancer NOGGO MONITOR 11.
    Sci Rep. 2021;11:9774.
    PubMed    
    Abstract available

  89. LIU T, Chen J, Du Q, Liu J, et al
    Family with sequence similarity 83 member A promotes tumor cell proliferation and metastasis and predicts poor prognosis in cervical cancer.
    Pathol Res Pract. 2021;222:153450.
    PubMed    
    Abstract available

  90. FUKAI S, Lefor AK, Mizokami K
    Laparoscopic appendectomy for metastatic cervical cancer presenting as appendicitis.
    Surg Case Rep. 2021;7:114.
    PubMed    
    Abstract available

  91. LIN CL, Ying TH, Yang SF, Chiou HL, et al
    MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis.
    Cell Death Dis. 2021;12:451.
    PubMed    
    Abstract available

  92. MAUGERI A, Barchitta M, Magnano San Lio R, Scalisi A, et al
    Antioxidant and inflammatory potential of diet among women at risk of cervical cancer: findings from a cross-sectional study in Italy.
    Public Health Nutr. 2021 May 7:1-23. doi: 10.1017/S1368980021001944.
    PubMed    
    Abstract available

  93. YAN W, Jin H, Zhang X, Long S, et al
    Identification of an immune signature to predict poor clinical outcome in cervical cancer.
    Epigenomics. 2021 May 6. doi: 10.2217/epi-2020-0437.
    PubMed    
    Abstract available

  94. HOU H, Dai Y, Liang S, Wang Z, et al
    Sentinel Lymph Node Biopsy Is Feasible in Cervical Cancer Laparoscopic Surgery: A Single-Center Retrospective Cohort Study.
    J Oncol. 2021;2021:5510623.
    PubMed    
    Abstract available

  95. WANG Y, Miao C, Gao X
    TCEB3 is Regulated by Circ-0000212/miR-140-3p Axis to Promote the Progression of Cervical Cancer.
    Onco Targets Ther. 2021;14:2853-2865.
    PubMed    
    Abstract available

  96. GAO J, Liu R, Feng D, Huang W, et al
    Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition.
    Cell Death Differ. 2021 May 5. pii: 10.1038/s41418-021-00786.
    PubMed    
    Abstract available

  97. PALMER M, Katanoda K, Saito E, Martellucci CA, et al
    National genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: a systematic review and meta-analysis protocol.
    Syst Rev. 2021;10:135.
    PubMed    
    Abstract available

  98. BALAYA V, Guani B, Pache B, Durand YG, et al
    Sentinel lymph node in cervical cancer: time to move forward.
    Chin Clin Oncol. 2021;10:18.
    PubMed    
    Abstract available

  99. HENGLIAN L, Jiajun W, Caixia W, Gang L, et al
    Analysis of related risk factors of lung metastasis after laparoscopic radical hysterectomy of cervical cancer.
    Medicine (Baltimore). 2021;100:e24480.
    PubMed    
    Abstract available

  100. ALVES MELO IM, Pereira Viana MR, Pupin B, Bhattacharjee TT, et al
    PCR-RFLP and FTIR-based detection of high-risk human papilloma virus for cervical cancer screening and prevention.
    Biochem Biophys Rep. 2021;26:100993.
    PubMed    
    Abstract available

  101. ZHANG J, Sun M, Li N, Miao M, et al
    Contemporary external beam radiotherapy boost or high dose-rate brachytherapy boost for cervical cancer: a propensity-score-matched, nationwide, population-based cohort study.
    Am J Cancer Res. 2021;11:1719-1732.
    PubMed    
    Abstract available

  102. XU Y, Pan S, Chen H, Qian H, et al
    MEX3A suppresses proliferation and EMT via inhibiting Akt signaling pathway in cervical cancer.
    Am J Cancer Res. 2021;11:1446-1462.
    PubMed    
    Abstract available

  103. HATTORI S, Yoshikawa N, Mogi K, Yoshida K, et al
    Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer.
    Curr Oncol. 2021;28:1663-1672.
    PubMed    
    Abstract available

  104. OANY AR, Mia M, Pervin T, Alyami SA, et al
    Integrative Systems Biology Approaches to Identify Potential Biomarkers and Pathways of Cervical Cancer.
    J Pers Med. 2021;11.
    PubMed    
    Abstract available

  105. IGNAT RM, Coza D, Ignat P, Badea RI, et al
    Time Trends Analysis of Cervical Cancer Incidence in Cluj County, Romania, Using Data from a Population-Based Cancer Registry.
    Curr Oncol. 2021;28:1706-1717.
    PubMed    
    Abstract available

  106. NOVAK V, Ptacek J, Fiala P, Vlachova Z, et al
    Development and performance assessment of an advanced Lucas-Kanade algorithm for dose mapping of cervical cancer external radiotherapy and brachytherapy plans.
    J Appl Clin Med Phys. 2021 May 4. doi: 10.1002/acm2.13249.
    PubMed    
    Abstract available

  107. ZHOU P, Liu W, Cheng Y, Qian D, et al
    Nanoparticle-based applications for cervical cancer treatment in drug delivery, gene editing, and therapeutic cancer vaccines.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 May 4:e1718.
    PubMed    
    Abstract available

  108. LOTT BE, Halkiyo A, Kassa DW, Kebede T, et al
    Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia.
    BMC Womens Health. 2021;21:185.
    PubMed    
    Abstract available

  109. DROGE LH, von Sivers FF, Schirmer MA, Wolff HA, et al
    Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patient- and treatment-related parameters.
    Strahlenther Onkol. 2021 May 3. pii: 10.1007/s00066-021-01782.
    PubMed    
    Abstract available

  110. KILIC F, Cakir C, Yuksel D, Korkmaz V, et al
    Analysis of the prognostic factors determining the oncological outcomes in patients with high-risk early-stage cervical cancer.
    J Obstet Gynaecol. 2021 May 2:1-8. doi: 10.1080/01443615.2021.1882974.
    PubMed    
    Abstract available

  111. OCADIZ-DELGADO R, Cruz-Colin JL, Alvarez-Rios E, Torres-Carrillo A, et al
    Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein.
    J Physiol Biochem. 2021 May 3. pii: 10.1007/s13105-021-00818.
    PubMed    
    Abstract available

  112. WANG X, Zhang B, He Q, Kong Y, et al
    Rectum Protection by Rectal Gel Injection in Cervical Cancer Brachytherapy: A Dosimetric Study via Deformable Surface Dose Accumulation and Machine-Learning-Based Discriminative Modeling.
    Front Oncol. 2021;11:657208.
    PubMed    
    Abstract available

  113. TOMIZAWA K, Ando K, Shimada H, Kaminuma T, et al
    Rectovaginal fistula in a cervical cancer patient treated with sequential radiotherapy and bevacizumab: A dose-volume analysis.
    Clin Case Rep. 2021;9:2099-2104.
    PubMed    
    Abstract available

  114. P MATYLEVICH O, B Shushkevich A, A Suslova V, A Perevoschikov P, et al
    Modified combined radiotherapy for cervical cancer in kidney transplant recipient.
    Clin Case Rep. 2021;9:2088-2093.
    PubMed    
    Abstract available

  115. TAO L, Liu S, Xiong J, Yang H, et al
    IL-1beta promotes cervical cancer through activating NF-kappaB/CCL-2.
    Int J Clin Exp Pathol. 2021;14:426-433.
    PubMed    
    Abstract available

  116. HAO X, Sun X, Zhu H, Xie L, et al
    Hydroxypropyl-beta-Cyclodextrin-Complexed Resveratrol Enhanced Antitumor Activity in a Cervical Cancer Model: In Vivo Analysis.
    Front Pharmacol. 2021;12:573909.
    PubMed    
    Abstract available

  117. NASSALI MN, Melese T, Modimowame J, Moreri-Ntshabele B, et al
    Timelines to Cervical Cancer Diagnosis and Treatment at a Tertiary Hospital in Botswana.
    Int J Womens Health. 2021;13:385-393.
    PubMed    
    Abstract available

  118. APU MNH, Aktar MN, Rahman MM, Mostaid MS, et al
    Association of TGFB1 gene polymorphisms with cervical cancer in Bangladeshi women: A case-control study.
    Tumour Biol. 2021;43:27-35.
    PubMed    
    Abstract available

  119. LEE G, Dee EC, Orav EJ, Kim DW, et al
    Association of Medicaid expansion and insurance status, cancer stage, treatment and mortality among patients with cervical cancer.
    Cancer Rep (Hoboken). 2021 May 2:e1407. doi: 10.1002/cnr2.1407.
    PubMed    
    Abstract available

  120. CHALI K, Oljira D, Sileshi T, Mekonnen T, et al
    Knowledge on cervical cancer, attitude toward its screening, and associated factors among reproductive age women in Metu Town, Ilu Aba Bor, South West Ethiopia, 2018: community-based cross-sectional study.
    Cancer Rep (Hoboken). 2021 May 2:e1382. doi: 10.1002/cnr2.1382.
    PubMed    
    Abstract available

  121. MACIOS A, Didkowska J, Wojciechowska U, Komerska K, et al
    Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
    Cancer Med. 2021 May 2. doi: 10.1002/cam4.3857.
    PubMed    
    Abstract available

  122. LAKSHMI BA, Reddy AS, Sangubotla R, Hong JW, et al
    Ruthenium(II)-curcumin liposome nanoparticles: Synthesis, characterization, and their effects against cervical cancer.
    Colloids Surf B Biointerfaces. 2021;204:111773.
    PubMed    
    Abstract available

  123. SHAO Y, Zhu F, Zhu S, Bai L, et al
    HDAC6 suppresses microRNA-199a transcription and augments HPV-positive cervical cancer progression through Wnt5a upregulation.
    Int J Biochem Cell Biol. 2021 Apr 29:106000. doi: 10.1016/j.biocel.2021.106000.
    PubMed    
    Abstract available

  124. ZHENG XD, Chen GY, Huang SF
    [Updates on adenocarcinomas of the uterine corpus and the cervix in the 5th edition of WHO classification of the female genital tumors].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:437-441.
    PubMed    


  125. MABEYA H, Odunga J, Broeck DV
    Mothers of adolescent girls and Human Papilloma Virus (HPV) vaccination in Western Kenya.
    Pan Afr Med J. 2021;38:126.
    PubMed    
    Abstract available

  126. DANIELS V, Saxena K, Roberts C, Kothari S, et al
    Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00428.
    PubMed    
    Abstract available

  127. OSMANI V, Klug SJ
    [HPV vaccination and the prevention of genital warts and precancerous lesions-current evidence and evaluation].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021.
    PubMed    
    Abstract available

  128. CAI T, Wu W, Guo L, Xia Y, et al
    Notoginsenoside R1 induces DNA damage via PHF6 protein to inhibit cervical carcinoma cell proliferation.
    Mol Med Rep. 2021;23.
    PubMed    
    Abstract available

  129. MOLINA-BARCELO A, Moreno Salas J, Peiro-Perez R, Arroyo G, et al
    [Inequalities in access to cancer screening programmes in Spain and how to reduce them: data from 2013 and 2020.]
    Rev Esp Salud Publica. 2021;95.
    PubMed    
    Abstract available

  130. KWON EJ, Ha M, Jang JY, Kim YH, et al
    Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
    J Virol. 2021;95.
    PubMed    
    Abstract available

  131. GENOVESE C, Squeri R, Alessi V, Conti A, et al
    Adherence to the three Italian screening in a sample of women (and men) in the Southern Italy.
    Clin Ter. 2021;171:e75-e79.
    PubMed    
    Abstract available

  132. SABET F, Mosavat A, Ahmadi Ghezeldasht S, Basharkhah S, et al
    Prevalence, genotypes and phylogenetic analysis of human papillomaviruses (HPV) in northeast Iran.
    Int J Infect Dis. 2021;103:480-488.
    PubMed    
    Abstract available

  133. BRITO MJ, Sequeira P, Silva I, Quintas A, et al
    CD4(+) and CD8(+) cell populations in HIV-positive women with cervical squamous intra-epithelial lesions and squamous cell carcinoma.
    Int J Infect Dis. 2021;103:370-377.
    PubMed    
    Abstract available

  134. LAGO V, Tiermes M, Padilla-Iserte P, Matute L, et al
    Protective Maneuver to Avoid Tumor Spillage during Laparoscopic Radical Hysterectomy: Vaginal Cuff Closure.
    J Minim Invasive Gynecol. 2021;28:174-175.
    PubMed    
    Abstract available

  135. NATALE C, Leinwand G, Zeineddine F, Silberstein JL, et al
    Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
    Cancer Treat Res Commun. 2020;24:100177.
    PubMed    
    Abstract available

  136. YAP RV, Santos AM, Roble VM 2nd
    Large benign schwannoma of the greater omentum with synchronous cervical cancer: A case report.
    Int J Surg Case Rep. 2021;83:105961.
    PubMed    
    Abstract available

  137. AFTAB M, Poojary SS, Seshan V, Kumar S, et al
    Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer.
    Sci Rep. 2021;11:10323.
    PubMed    
    Abstract available

  138. DASS SA, Selva Rajan R, Tye GJ, Balakrishnan V, et al
    The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy.
    Hum Vaccin Immunother. 2021 May 14:1-14. doi: 10.1080/21645515.2021.1913960.
    PubMed    
    Abstract available

  139. QI X, Fu Y, Sheng J, Zhang M, et al
    A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer.
    Bioengineered. 2021;12:1813-1825.
    PubMed    
    Abstract available

  140. ZHU X, MacLaughlin KL, Fan C, Jacobson DJ, et al
    Awareness of HPV Testing and Acceptability of Self-sampling for Cervical Cancer Screening Among Women in Minnesota.
    J Gen Intern Med. 2021 May 13. pii: 10.1007/s11606-021-06854.
    PubMed    


  141. HEIDEMANN DL, Adhami A, Nair A, Haftka-George A, et al
    Using a Frontline Staff Intervention to Improve Cervical Cancer Screening in a Large Academic Internal Medicine Clinic.
    J Gen Intern Med. 2021 May 13. pii: 10.1007/s11606-021-06865.
    PubMed    
    Abstract available

  142. BUSTAMANTE G, Reiter PL, McRee AL
    Cervical cancer screening among sexual minority women: findings from a national survey.
    Cancer Causes Control. 2021 May 13. pii: 10.1007/s10552-021-01442.
    PubMed    
    Abstract available

  143. YANG B, Chen J, Teng Y
    TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer.
    J Immunol Res. 2021;2021:9994004.
    PubMed    
    Abstract available

  144. ZHANG J, Cao D, Yang J, Shen K, et al
    Tumor Volume Predicts High-Risk Patients and Guides Initial Chemoradiotherapy for Early Cervical Cancer.
    Front Oncol. 2021;11:640846.
    PubMed    
    Abstract available

  145. CHEN M, Chi Y, Chen H, Zhao L, et al
    Long non-coding RNA USP30-AS1 aggravates the malignant progression of cervical cancer by sequestering microRNA-299-3p and thereby overexpressing PTP4A1.
    Oncol Lett. 2021;22:505.
    PubMed    
    Abstract available

  146. KISS SL, Fandi A, Cozlea AL, Gheorghe M, et al
    Abdominal radical trachelectomy as fertility-sparing management for early stages of cervical cancer: Our experience in 18 cases.
    Exp Ther Med. 2021;22:674.
    PubMed    
    Abstract available

  147. BIAN S, Zhao Y, Li F, Lu S, et al
    Total ginsenosides induce autophagic cell death in cervical cancer cells accompanied by downregulation of bone marrow stromal antigen-2.
    Exp Ther Med. 2021;22:667.
    PubMed    
    Abstract available

  148. HADAMI K, Saby C, Dakka N, Collin G, et al
    Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women.
    Gene. 2021 May 10:145709. doi: 10.1016/j.gene.2021.145709.
    PubMed    
    Abstract available

  149. ALBUQUERQUE T, Cruz R, Cardoso JS
    Ordinal losses for classification of cervical cancer risk.
    PeerJ Comput Sci. 2021;7:e457.
    PubMed    
    Abstract available

  150. SAFAEIAN F, Ghaemimood S, El-Khatib Z, Enayati S, et al
    Burden of Cervical Cancer in the Eastern Mediterranean Region During the Years 2000 and 2017: Retrospective Data Analysis of the Global Burden of Disease Study.
    JMIR Public Health Surveill. 2021;7:e22160.
    PubMed    
    Abstract available

  151. KE J, Gu C, Zhang H, Liu Y, et al
    Nucleolin Promotes Cisplatin Resistance in Cervical Cancer by the YB1-MDR1 Pathway.
    J Oncol. 2021;2021:9992218.
    PubMed    
    Abstract available

  152. AFANASIEV M, Dushkin A, Grishacheva T, Afanasiev S, et al
    The Multi-Course Approach of Photodynamic Therapy to Treat Invasive Cervical Cancer IB2: A Case Report.
    Case Rep Oncol. 2021;14:506-519.
    PubMed    
    Abstract available

  153. WASSIE M, Fentie B
    Prevalence of late-stage presentation and associated factors of cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia: institutional based cross-sectional study.
    Infect Agent Cancer. 2021;16:30.
    PubMed    
    Abstract available

  154. LI X, Liu M, Ji Y, Qu P, et al
    The effectiveness of cold-knife conization (CKC) for post-menopausal women with cervical high-grade squamous intraepithelial lesion: a retrospective study.
    BMC Surg. 2021;21:241.
    PubMed    
    Abstract available

  155. ZHANG X, Zeng Q, Cai W, Ruan W, et al
    Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019.
    BMC Public Health. 2021;21:894.
    PubMed    
    Abstract available

  156. WANG W, Jiao Y, Zhang L, Fu C, et al
    Multiparametric MRI-based radiomics analysis: differentiation of subtypes of cervical cancer in the early stage.
    Acta Radiol. 2021 May 11:2841851211014188. doi: 10.1177/02841851211014188.
    PubMed    
    Abstract available

  157. ZNAOR A, Ryzhov A, Corbex M, Pineros M, et al
    Cervical cancer in the Newly Independent States of the former Soviet Union: Incidence will remain high without action.
    Cancer Epidemiol. 2021;73:101944.
    PubMed    


  158. LIU Y, Fan H, Dong D, Liu P, et al
    Computed tomography-based radiomic model at node level for the prediction of normal-sized lymph node metastasis in cervical cancer.
    Transl Oncol. 2021;14:101113.
    PubMed    
    Abstract available

  159. ARBYN M, Simon M, Peeters E, Meijer CJLM, et al
    2020 List of human papillomavirus assays Suitable for primary cervical cancer screening.
    Clin Microbiol Infect. 2021 May 8. pii: S1198-743X(21)00219.
    PubMed    
    Abstract available

  160. GUO W, Zhu J, Zhu Y, Wang K, et al
    G2 and S phase-expressed-1 acts as a putative tumor promoter in cervical cancer by enhancing Wnt/beta-catenin signaling via modulation of GSK-3beta.
    Environ Toxicol. 2021 May 11. doi: 10.1002/tox.23158.
    PubMed    
    Abstract available

  161. MATSUO K, Chang EJ, Matsuzaki S, Shimada M, et al
    Recent changes in demographics and outcomes of cervical cancer in the United States.
    Arch Gynecol Obstet. 2021 May 11. pii: 10.1007/s00404-021-06092.
    PubMed    


  162. AHMAD N, Ali SS, Ahmad S, Hussain Z, et al
    Computational Modeling of Immune Response Triggering Immunogenic Peptide Vaccine Against the Human Papillomaviruses to Induce Immunity Against Cervical Cancer.
    Viral Immunol. 2021 May 10. doi: 10.1089/vim.2020.0306.
    PubMed    
    Abstract available

  163. BAETEN IGT, Hoogendam JP, Jeremiasse B, Braat AJAT, et al
    Indocyanine green versus technetium-99m with blue dye for sentinel lymph node detection in early-stage cervical cancer: A systematic review and meta-analysis.
    Cancer Rep (Hoboken). 2021 May 11:e1401. doi: 10.1002/cnr2.1401.
    PubMed    
    Abstract available

  164. LI QZ, Sun LP, Shi HY, Chen Y, et al
    The new-generation proteasome inhibitor oprozomib increases the sensitivity of cervical cancer cells to cisplatin-induced apoptosis.
    J Biol Regul Homeost Agents. 2021;35:559-569.
    PubMed    
    Abstract available

  165. CAPOZZI VA, Sozzi G, Monfardini L, Di Donna MC, et al
    Transperitoneal versus extraperitoneal laparoscopic aortic lymph nodal staging for locally advanced cervical cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021 May 1. pii: S0748-7983(21)00467.
    PubMed    
    Abstract available

  166. LYU X, Li G, Qiao Q
    Identification of an immune classification for cervical cancer and integrative analysis of multiomics data.
    J Transl Med. 2021;19:200.
    PubMed    
    Abstract available

  167. HU Y, Xie H, Liu Y, Liu W, et al
    Retraction Note to: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
    Cancer Cell Int. 2021;21:255.
    PubMed    


  168. SUN TX, Li MY, Zhang ZH, Wang JY, et al
    Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD-L1 expression and enhancing T-lymphocyte tumor-killing activity.
    Phytother Res. 2021 May 10. doi: 10.1002/ptr.7103.
    PubMed    
    Abstract available

  169. SHI X, Xu M, Luo K, Huang W, et al
    Anticancer activity of bergenin against cervical cancer cells involves apoptosis, cell cycle arrest, inhibition of cell migration and the STAT3 signalling pathway.
    Exp Ther Med. 2021;21:653.
    PubMed    
    Abstract available

  170. WU PJ, Wang CH, Hsieh MH, Lee CY, et al
    The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.
    Int J Med Sci. 2021;18:2457-2465.
    PubMed    
    Abstract available

  171. LI Y, Li C, Liu S, Yang J, et al
    The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer.
    Int J Med Sci. 2021;18:2347-2354.
    PubMed    
    Abstract available

  172. SUN YH, Chou YH, Wang CH, Hsiao YH, et al
    Impact of pentraxin 3 genetic variants on uterine cervical cancer clinicopathologic characteristics.
    Int J Med Sci. 2021;18:2339-2346.
    PubMed    
    Abstract available

  173. GUO M, Shlyakhova N, Khanna A, Tinnirello AA, et al
    Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
    J Am Soc Cytopathol. 2021 Apr 19. pii: S2213-2945(21)00044.
    PubMed    
    Abstract available

  174. WU CY, Chan TF, Shi HY, Kuo YL, et al
    Psychiatric problems of anxiety and depression disorder are associated with medical service utilization and survival among patients with cervical cancer.
    Taiwan J Obstet Gynecol. 2021;60:474-479.
    PubMed    
    Abstract available

  175. LEE CL, Huang KG, Chua PT, Mendoza MCVR, et al
    Standardization and experience may influence the survival of laparoscopic radical hysterectomy for cervical cancer.
    Taiwan J Obstet Gynecol. 2021;60:463-467.
    PubMed    
    Abstract available

  176. XU Y, Zhang M, Zhang J, Ng DM, et al
    Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.
    Taiwan J Obstet Gynecol. 2021;60:433-441.
    PubMed    
    Abstract available

  177. LIU Y, Tian L, You J, Li Y, et al
    The predictive value of postoperative C-reactive protein (CRP), procalcitonin (PCT) and triggering receptor expressed on myeloid cells 1 (TREM-1) for the early detection of pulmonary infection following laparoscopic general anesthesia for cervical can
    Ann Palliat Med. 2021;10:4502-4508.
    PubMed    
    Abstract available

  178. ZHOU L, Xu XL
    Long Non-Coding RNA ARAP1-AS1 Facilitates the Progression of Cervical Cancer by Regulating miR-149-3p and POU2F2.
    Pathobiology. 2021 May 7:1-12. doi: 10.1159/000507830.
    PubMed    
    Abstract available

  179. ABBAS APM, Mehdi APA, Khan PRFH, Verma APS, et al
    Role of miRNAs in cervical cancer: A comprehensive novel approach from pathogenesis to therapy.
    J Gynecol Obstet Hum Reprod. 2021 May 6:102159. doi: 10.1016/j.jogoh.2021.102159
    PubMed    
    Abstract available

  180. DEL VALLE-MENDOZA J, Becerra-Goicochea L, Aguilar-Luis MA, Pinillos-Vilca L, et al
    Genotype-specific prevalence of human papillomavirus infection in asymptomatic Peruvian women: a community-based study.
    BMC Res Notes. 2021;14:172.
    PubMed    
    Abstract available

  181. GAVAMUKULYA Y, Maina EN, El-Shemy HA, Meroka AM, et al
    Annona muricata silver nanoparticles exhibit strong anticancer activities against cervical and prostate adenocarcinomas through regulation of CASP9 and the CXCL1/CXCR2 genes axis.
    Tumour Biol. 2021;43:37-55.
    PubMed    
    Abstract available

  182. LIU Y, Zhao M, Shao Y, Yan L, et al
    Chemical composition of surgical smoke produced during the loop electrosurgical excision procedure when treating cervical intraepithelial neoplasia.
    World J Surg Oncol. 2021;19:103.
    PubMed    
    Abstract available

  183. LIANG Y, Pan C, Sun W, Liu Q, et al
    Global context-aware cervical cell detection with soft scale anchor matching.
    Comput Methods Programs Biomed. 2021;204:106061.
    PubMed    
    Abstract available

  184. QADERI K, Geranmayeh M, Farnam F, Sheikh Hasani S, et al
    Understanding HPV-positive women's needs and experiences in relation to patient-provider communication issues: a qualitative study.
    BMC Health Serv Res. 2021;21:286.
    PubMed    
    Abstract available

  185. DING HM, Zhang H, Wang J, Zhou JH, et al
    miR302c3p and miR520a3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8.
    Mol Med Rep. 2021;23.
    PubMed    
    Abstract available

  186. LU Z, Guo C, Wang T, Qiu J, et al
    Characteristics, complications, and outcomes of early-stage cervical stump carcinoma: laparoscopy versus laparotomy.
    J Int Med Res. 2021;49:300060521992247.
    PubMed    
    Abstract available

  187. MANLUBATAN SIT, Lopez MPJ, Garcia CMH, Gaston CLL, et al
    En bloc resection of cervical adenocarcinoma with late recurrence to the iliopsoas.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  188. HONG G, Zou Z, Huang Z, Deng H, et al
    Split-type electrochemiluminescent gene assay platform based on gold nanocluster probe for human papillomavirus diagnosis.
    Biosens Bioelectron. 2021;178:113044.
    PubMed    
    Abstract available

  189. BOUSTANI J, Achkar S, Bertaut A, Genestie C, et al
    Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center.
    Cancer Radiother. 2021;25:207-212.
    PubMed    
    Abstract available

  190. CARRILLO-NG H, Becerra-Goicochea L, Tarazona-Castro Y, Pinillos-Vilca L, et al
    Variations in cervico-vaginal microbiota among HPV-positive and HPV-negative asymptomatic women in Peru.
    BMC Res Notes. 2021;14:4.
    PubMed    
    Abstract available

  191. SHRIVASTAVA A, Aggarwal LM, Murali Krishna C, Pradhan S, et al
    Diagnostic and prognostic application of Raman spectroscopy in carcinoma cervix: A biomolecular approach.
    Spectrochim Acta A Mol Biomol Spectrosc. 2021;250:119356.
    PubMed    
    Abstract available

  192. GU L, Cheng M, Hong Z, Di W, et al
    The effect of local photodynamic therapy with 5-aminolevulinic acid for the treatment of cervical low-grade squamous intraepithelial lesions with high-risk HPV infection: A retrospective study.
    Photodiagnosis Photodyn Ther. 2021;33:102172.
    PubMed    
    Abstract available

  193. YOGO K, Noguchi Y, Okudaira K, Nozawa M, et al
    Source position measurement by Cherenkov emission imaging from applicators for high-dose-rate brachytherapy.
    Med Phys. 2021;48:488-499.
    PubMed    
    Abstract available

  194. ZHANG H, Cheng C, Gao R, Yan Z, et al
    Rapid identification of cervical adenocarcinoma and cervical squamous cell carcinoma tissue based on Raman spectroscopy combined with multiple machine learning algorithms.
    Photodiagnosis Photodyn Ther. 2021;33:102104.
    PubMed    
    Abstract available

  195. SHI J, Wang R, Zheng Y, Jiang Z, et al
    Cervical cell classification with graph convolutional network.
    Comput Methods Programs Biomed. 2021;198:105807.
    PubMed    
    Abstract available

  196. RIZZO G, Pietrolucci ME, Mappa I, Bitsadze V, et al
    Sonoelastographic Assessment of the Uterine Cervix in the Prediction of Imminent Delivery in Singleton Nulliparous Women Near Term: A Prospective Cohort Study.
    J Ultrasound Med. 2021;40:559-568.
    PubMed    
    Abstract available

  197. HAYASHI A, Matsumoto K, Mitsuishi T
    Three cases of recalcitrant cutaneous warts treated with quadrivalent human papillomavirus vaccine: the HPV type may not determine the outcome.
    Br J Dermatol. 2019 Nov 1. doi: 10.1111/bjd.18645.
    PubMed    
    Abstract available

  198. LEEMAN A, Jenkins D, Marra E, van Zummeren M, et al
    Grading immunohistochemical markers p16(INK4a) and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions.
    Br J Dermatol. 2019 Jul 14. doi: 10.1111/bjd.18342.
    PubMed    
    Abstract available

  199. CASTANON A, Green LI, Sasieni P
    Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study.
    Prev Med. 2021 May 18:106625. doi: 10.1016/j.ypmed.2021.106625.
    PubMed    
    Abstract available

  200. PRY JM, Manasyan A, Kapambwe S, Taghavi K, et al
    Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
    Lancet Glob Health. 2021;9:e832-e840.
    PubMed    
    Abstract available

  201. NYAMBE A, Lubeya MK
    Cervical cancer and HIV in Zambian women.
    Lancet Glob Health. 2021;9:e734-e735.
    PubMed    


  202. MANEENET J, Omar AM, Sun S, Kim MJ, et al
    Benzylisoquinoline alkaloids from Nelumbo nucifera Gaertn. petals with antiausterity activities against the HeLa human cervical cancer cell line.
    Z Naturforsch C J Biosci. 2021 May 21. pii: znc-2020-0304.
    PubMed    
    Abstract available

  203. TAN YL, Chen H, Wu ZK, He J, et al
    Digital Loop-Mediated Isothermal Amplification-Based Absolute Methylation Quantification Revealed Hypermethylated DAPK1 in Cervical Cancer Patients.
    Anal Chem. 2021 May 21. doi: 10.1021/acs.analchem.1c01510.
    PubMed    
    Abstract available

  204. BENARD VB, Jackson JE, Greek A, Senkomago V, et al
    A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.
    Cancer Med. 2021 May 21. doi: 10.1002/cam4.3951.
    PubMed    
    Abstract available

  205. MOU C, Lu FJ, Yu B, Xiao ZB, et al
    [The Value of MRI in Early Cervical Cancer Staging with Vaginal Filling of Ultrasound Gel].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52:523-527.
    PubMed    
    Abstract available

  206. LUO GP, Zeng X, Cao HY, Tang D, et al
    [The Clinical Significance of HPV L1/PD-L1 Tests Combined with Colposcopy for Cervical Precancerous Lesions and Cervical Cancer].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52:516-522.
    PubMed    
    Abstract available

  207. PATEL IS, Dongara AR, Mungala BM, Chapla A, et al
    Knowledge and attitude about cervical cancer and human papillomavirus vaccine among medical and paramedical students of a university.
    J Family Med Prim Care. 2021;10:462-467.
    PubMed    
    Abstract available

  208. LIU Y, Zang C, Qian L, Wu A, et al
    The effect of dose-painted intensity-modulated radiotherapy combined with chemotherapy for stage IIIB cervical cancer.
    Am J Transl Res. 2021;13:2813-2821.
    PubMed    
    Abstract available

  209. WANG J, Chen H, Hu Z, Ma K, et al
    Hesperetin regulates transforming growth factor-beta1/Smads pathway to suppress epithelial-mesenchymal transition -mediated invasion and migration in cervical cancer cell.
    Anticancer Drugs. 2021 May 19. pii: 00001813-900000000-98412.
    PubMed    
    Abstract available

  210. WANG Y, Jin G, Guo Y, Cao Y, et al
    SMYD2 suppresses p53 activity to promote glucose metabolism in cervical cancer.
    Exp Cell Res. 2021 May 17:112649. doi: 10.1016/j.yexcr.2021.112649.
    PubMed    
    Abstract available

  211. YIN Q, Chen H, Ma RH, Zhang YY, et al
    Ginsenoside CK induces apoptosis of human cervical cancer HeLa cells by regulating autophagy and endoplasmic reticulum stress.
    Food Funct. 2021 May 20. doi: 10.1039/d1fo00348.
    PubMed    
    Abstract available

  212. ZHANG S, Fu X
    The Clinical Significance and Biological Function of PCDH7 in Cervical Cancer.
    Cancer Manag Res. 2021;13:3841-3847.
    PubMed    
    Abstract available

  213. MEHTA N, Desai SM, Dhakad V, Patel D, et al
    Treatment and Outcomes of Early and Operable Recurrent Cervical Cancer: A Prospective Study.
    Niger J Surg. 2021;27:28-32.
    PubMed    
    Abstract available

  214. MURAKAMI N, Asami Y, Yoshida H, Takayanagi D, et al
    Distribution of genetic alterations in high-risk early-stage cervical cancer patients treated with postoperative radiation therapy.
    Sci Rep. 2021;11:10567.
    PubMed    
    Abstract available

  215. NISHIMURA H, Yeh PT, Oguntade H, Kennedy CE, et al
    HPV self-sampling for cervical cancer screening: a systematic review of values and preferences.
    BMJ Glob Health. 2021;6.
    PubMed    
    Abstract available

  216. HUANG X, He M, Peng H, Tong C, et al
    Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
    J Immunother Cancer. 2021;9.
    PubMed    
    Abstract available

  217. CHOI JA, Kim O
    Cervical Cancer Prevention Education Program for Rural Korean Immigrant Women.
    West J Nurs Res. 2021 May 19:1939459211014111. doi: 10.1177/01939459211014111.
    PubMed    
    Abstract available

  218. RANDALL LM, Walker AJ, Jia AY, Miller DT, et al
    Expanding Our Impact in Cervical Cancer Treatment: Novel Immunotherapies, Radiation Innovations, and Consideration of Rare Histologies.
    Am Soc Clin Oncol Educ Book. 2021;41:252-263.
    PubMed    
    Abstract available

  219. KHAMIS SI, Mrema AS, Katanga J, Lugina EL, et al
    Survival in Cervical Cancer and Its Predictors at Ocean Road Cancer Institute From January to December 2012.
    JCO Glob Oncol. 2021;7:734-739.
    PubMed    
    Abstract available

  220. KUGUYO O, Misi FD, Chibonda S, Matimba A, et al
    Pain management strategies among cervical cancer patients in Zimbabwe.
    Pain Manag. 2021 May 19. doi: 10.2217/pmt-2020-0108.
    PubMed    
    Abstract available

  221. QIN J, Song G, Wang Y, Liu Q, et al
    Ultrasound irradiation inhibits proliferation of cervical cancer cells by initiating endoplasmic reticulum stress-mediated apoptosis and triggering phosphorylation of JNK.
    Adv Clin Exp Med. 2021 May 18. doi: 10.17219/acem/133488.
    PubMed    
    Abstract available

  222. BAESSLER K, Windemut S, Chiantera V, Kohler C, et al
    Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical cancer.
    Clin Transl Oncol. 2021 May 18. pii: 10.1007/s12094-021-02632.
    PubMed    
    Abstract available

  223. SHIBUTANI T, Nagao S, Suzuki K, Yamamoto K, et al
    Treatment strategy for locally advanced squamous cell cervical cancer with clinically positive pelvic lymph nodes metastasis.
    J Obstet Gynaecol Res. 2021 May 17. doi: 10.1111/jog.14816.
    PubMed    
    Abstract available

  224. OMORI M, Ogawa T, Oyama K, Tagaya H, et al
    Leptomeningeal metastasis from cervical cancer: Report of two cases and a review of the literature.
    J Obstet Gynaecol Res. 2021 May 17. doi: 10.1111/jog.14825.
    PubMed    
    Abstract available

  225. AYATILAKEBANDA I, Tsang YM, Hoskin P
    High dose simultaneous integrated boost for node positive cervical cancer.
    Radiat Oncol. 2021;16:92.
    PubMed    
    Abstract available

  226. DE BRUYN A, Peeters F, Smulders K, Goffin F, et al
    Observational BGOG Study Of The Results Of Robot-Assisted Laparoscopy In 166 Patients With FiGO 2009 Stage Ia1- Ib1 Cervical Cancer.
    J Minim Invasive Gynecol. 2021 May 14. pii: S1553-4650(21)00223.
    PubMed    
    Abstract available

  227. KRASZNAI ZT, Bagoly Z, Nagy E, Farkas Z, et al
    Multimodal hyperspectroscopy - the use of digital technology in cervical cancer screening
    Orv Hetil. 2021;162:790-799.
    PubMed    
    Abstract available

  228. GUPTA N, Chauhan AS, Prinja S, Pandey AK, et al
    Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India.
    JCO Glob Oncol. 2021;7:716-725.
    PubMed    
    Abstract available

  229. MUNGO C, Osongo CO, Ambaka J, Randa MA, et al
    Feasibility and Acceptability of Smartphone-Based Cervical Cancer Screening Among HIV-Positive Women in Western Kenya.
    JCO Glob Oncol. 2021;7:686-693.
    PubMed    
    Abstract available

  230. LIU Y, Xu Y, Jiang W, Ji H, et al
    Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer.
    Mol Ther Methods Clin Dev. 2021;21:492-506.
    PubMed    
    Abstract available

  231. CHANDRAN V, Sumithra MG, Karthick A, George T, et al
    Diagnosis of Cervical Cancer based on Ensemble Deep Learning Network using Colposcopy Images.
    Biomed Res Int. 2021;2021:5584004.
    PubMed    
    Abstract available

  232. SANDERS JC, Muller DA, Dutta SW, Corriher TJ, et al
    Para-Aortic Nodal Radiation in the Definitive Management of Node-Positive Cervical Cancer.
    Front Oncol. 2021;11:664714.
    PubMed    
    Abstract available

  233. XU M, Wu Q, Cai L, Sun X, et al
    Systemic Inflammatory Score predicts Overall Survival in patients with Cervical Cancer.
    J Cancer. 2021;12:3671-3677.
    PubMed    
    Abstract available

  234. ZOU R, Gu R, Yu X, Hu Y, et al
    Characteristics of Infiltrating Immune Cells and a Predictive Immune Model for Cervical Cancer.
    J Cancer. 2021;12:3501-3514.
    PubMed    
    Abstract available

  235. DONG B, Zou H, Mao X, Su Y, et al
    Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study.
    Ther Adv Med Oncol. 2021;13:17588359211010939.
    PubMed    
    Abstract available

  236. CHIGOZIE N, Hilfinger Messiaa DK, Adebola A, Ojiegbe T, et al
    Men's willingness to support HPV vaccination and cervical cancer screening in Nigeria.
    Health Promot Int. 2021 May 16. pii: 6276503. doi: 10.1093.
    PubMed    
    Abstract available

  237. HALASKA MJ, Drochytek V, Shmakov RG, Amant F, et al
    Fertility sparing treatment in cervical cancer management in pregnancy.
    Best Pract Res Clin Obstet Gynaecol. 2021 Apr 22. pii: S1521-6934(21)00065.
    PubMed    
    Abstract available

  238. SCHROTZLMAIR F
    [Cervical mass].
    MMW Fortschr Med. 2021;163.
    PubMed    


  239. OLIVEIRA CR, Ortiz AM, Sheth SS, Shapiro ED, et al
    Effectiveness of HPV vaccine by age at vaccination and number of doses: protocol for a population-based matched case-control study.
    BMJ Open. 2021;11:e043093.
    PubMed    
    Abstract available

  240. LI S, Zhang Z, Liu J, Zhang F, et al
    The feasibility of a radial turbo-spin-echo T2 mapping for preoperative prediction of the histological grade and lymphovascular space invasion of cervical squamous cell carcinoma.
    Eur J Radiol. 2021;139:109684.
    PubMed    
    Abstract available

  241. ARAFAH M, Rashid S, Tulbah A, Akhtar M, et al
    Carcinomas of the Uterine Cervix: Comprehensive Review With An Update on Pathogenesis, Nomenclature of Precursor and Invasive Lesions, and Differential Diagnostic Considerations.
    Adv Anat Pathol. 2021;28:150-170.
    PubMed    
    Abstract available

  242. KURUC T, Kello M, Petrova K, Kudlickova Z, et al
    The Newly Synthetized Chalcone L1 Is Involved in the Cell Growth Inhibition, Induction of Apoptosis and Suppression of Epithelial-to-Mesenchymal Transition of HeLa Cells.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  243. ORNSKOV D, Jochumsen K, Steiner PH, Grunnet IM, et al
    Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women referred for colposcopy. A cross-sectional study.
    BMJ Open. 2021;11:e041512.
    PubMed    
    Abstract available

  244. WHITWORTH HS, Schiller J, Markowitz LE, Jit M, et al
    Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule.
    Vaccine. 2021 Jan 13. pii: S0264-410X(20)31598.
    PubMed    


  245. GUPTA B, Sunnam LB, Kumar A, Parikipandla S, et al
    Prevalence of human papillomavirus 16 genotype in Anuppur district, Madhya Pradesh.
    Mol Biol Rep. 2021;48:503-511.
    PubMed    
    Abstract available

  246. ROUSSET-JABLONSKI C, Haesebaert J, Denis A, Reix P, et al
    Human Papilloma Virus Vaccination Among Female Patients Attending French Pediatric Cystic Fibrosis Centers.
    J Pediatr Adolesc Gynecol. 2021;34:317-323.
    PubMed    
    Abstract available

  247. MERRILL RM, Williams EN, Fuhriman H
    Risk Behaviors Correlate with Higher Prevalence of Papanicolaou, Human Papillomavirus, and Human Immunodeficiency Virus Screening Among Women in the United States.
    J Womens Health (Larchmt). 2021;30:615-624.
    PubMed    
    Abstract available

  248. HORNER MJ, Shiels MS, Pfeiffer RM, Engels EA, et al
    Deaths attributable to cancer in the United States HIV population during 2001-2015.
    Clin Infect Dis. 2020 Jul 25. pii: 5876399. doi: 10.1093/cid/ciaa1016.
    PubMed    
    Abstract available

  249. STIER EA, Engels E, Horner MJ, Robinson B, et al
    Cervical cancer incidence stratified by age in women living with HIV compared with the general population in the United States, 2002-2016.
    AIDS. 2021 May 27. pii: 00002030-900000000-96395.
    PubMed    
    Abstract available

  250. SRINIVAS V, Herbst De Cortina S, Nishimura H, Krupp K, et al
    Community-based Mobile Cervical Cancer Screening Program in Rural India: Successes and Challenges for Implementation.
    Asian Pac J Cancer Prev. 2021;22:1393-1400.
    PubMed    
    Abstract available

  251. CHAUDHRY GE, Islamiah M, Zafar MN, Bakar K, et al
    Induction of Apoptosis by Acanthaster planci sp., and Diadema setosum sp., Fractions in Human Cervical Cancer Cell Line, HeLa.
    Asian Pac J Cancer Prev. 2021;22:1365-1373.
    PubMed    
    Abstract available

  252. SUN T, Zhang D, Wang Z, Zhao B, et al
    Inhibition of the notch signaling pathway overcomes resistance of cervical cancer cells to paclitaxel through retardation of the epithelial-mesenchymal transition process.
    Environ Toxicol. 2021 May 28. doi: 10.1002/tox.23296.
    PubMed    
    Abstract available

  253. PANDEY P, Khan F, Maurya P
    Targeting Jab1 using hesperidin (dietary phytocompound) for inducing apoptosis in HeLa cervical cancer cells.
    J Food Biochem. 2021 May 27:e13800. doi: 10.1111/jfbc.13800.
    PubMed    
    Abstract available

  254. LI XJ, You Y, Zhang QL, Zhang BB, et al
    [Preparation of paclitaxel-loaded and folic acid-modified poly (lactic-co-glycolic acid) nano-micelles and in vitro anticancer effect on cervical cancer HeLa cells].
    Zhongguo Zhong Yao Za Zhi. 2021;46:2481-2488.
    PubMed    
    Abstract available

  255. DONG M, Li P, Xie Y, Wang Z, et al
    CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR-665-dependent regulation of EGFR.
    Drug Dev Res. 2021 May 27. doi: 10.1002/ddr.21834.
    PubMed    
    Abstract available

  256. DING B, Guan X, Duan K, Shen Y, et al
    Laparoscopic radical hysterectomy with enclosed colpotomy without the use of uterine manipulator for early-stage cervical cancer.
    J Minim Access Surg. 2021 May 1. pii: 315374. doi: 10.4103.
    PubMed    
    Abstract available

  257. JAQUET A, Boni S, Tchounga B, Comoe K, et al
    Changes in HIV-Related Cervical Cancer Over a Decade in Cote d'Ivoire.
    JCO Glob Oncol. 2021;7:782-789.
    PubMed    
    Abstract available

  258. ROSSMAN AH, Reid HW, Pieters MM, Mizelle C, et al
    Digital Health Strategies for Cervical Cancer Control in Low- and Middle-Income Countries: Systematic Review of Current Implementations and Gaps in Research.
    J Med Internet Res. 2021;23:e23350.
    PubMed    
    Abstract available

  259. DONG RF, Zhuang YJ, Wang Y, Zhang ZY, et al
    Tumor suppressor miR-192-5p targets TRPM7 and inhibits proliferation and invasion in cervical cancer.
    Kaohsiung J Med Sci. 2021 May 27. doi: 10.1002/kjm2.12398.
    PubMed    
    Abstract available

  260. MILLET N, McDermott HJ, Moss EL, Edwardson CL, et al
    Increasing physical activity levels following treatment for cervical cancer: an intervention mapping approach.
    J Cancer Surviv. 2021 May 26. pii: 10.1007/s11764-021-01058.
    PubMed    
    Abstract available

  261. YANG FC, Huang W, Yang W, Liu J, et al
    Cervical Cancer Surgery: Current State of Affairs.
    Gynecol Minim Invasive Ther. 2021;10:75-83.
    PubMed    
    Abstract available

  262. PURBADI S, Rustamadji P, Purwoto G, Kusuma F, et al
    Skin metastases originated from cervical cancer: A rare case report.
    Ann Med Surg (Lond). 2021;66:102363.
    PubMed    
    Abstract available

  263. REQUES L, Rolland C, Lallemand A, Lahmidi N, et al
    Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France.
    BMC Womens Health. 2021;21:221.
    PubMed    
    Abstract available

  264. KATO K, Okumura K, Suzuki S, Matsuyama A, et al
    Hyperammonemic encephalopathy associated with post-radiotherapy vesicointestinal fistula following cervical cancer.
    J Obstet Gynaecol Res. 2021 May 26. doi: 10.1111/jog.14865.
    PubMed    
    Abstract available

  265. WANG Q, Zhuo Z, Yu H, Wang C, et al
    Circ_0019435 Exerts Its Functions in the Cellular Process of Cervical Cancer via Epigenetically Silencing DKK1 and PTEN.
    Reprod Sci. 2021 May 26. pii: 10.1007/s43032-021-00625.
    PubMed    
    Abstract available

  266. FERREIRA M, Lovinfosse P, Hermesse J, Decuypere M, et al
    Correction to: [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation.
    Eur J Nucl Med Mol Imaging. 2021 May 26. pii: 10.1007/s00259-021-05397.
    PubMed    


  267. LI B, Guo R, Lai T, Qiao L, et al
    The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening.
    J Obstet Gynaecol Res. 2021 May 25. doi: 10.1111/jog.14869.
    PubMed    
    Abstract available

  268. DAHMAN A, McClelland D, Zaslau S, Turner VG, et al
    Utilizing Colpocleisis to Repair a Vesicovaginal Fistula in a Cervical Cancer Patient with History of Pelvic Radiation: A Case Report and Literature Review.
    Case Rep Urol. 2021;2021:8865146.
    PubMed    
    Abstract available

  269. XU R, Zhang X, Xu Y, Wang J, et al
    Long noncoding RNA MST1P2 promotes cervical cancer progression by sponging with microRNA miR-133b.
    Bioengineered. 2021;12:1851-1860.
    PubMed    
    Abstract available

  270. MA JH, Huang Y, Liu LY, Feng Z, et al
    An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
    J Int Med Res. 2021;49:3000605211018443.
    PubMed    
    Abstract available

  271. FOWLER JR, Maani EV, Jack BW, Miller JL, et al
    Breast and cervical cancer mortality in the western Amazon: A time series study between 1980 and 2014.
    Medicine (Baltimore). 2021;100:e26157.
    PubMed    
    Abstract available

  272. ISER IC, de Andrade Mello P, Davies S, de Souza Santos JF, et al
    A three-dimensional microenvironment alters CD73 expression in cervical cancer.
    Cell Biochem Funct. 2021 May 24. doi: 10.1002/cbf.3649.
    PubMed    
    Abstract available

  273. CHU D, Liu T, Yao Y, Luan N, et al
    LINC00997/miR-574-3p/CUL2 promotes cervical cancer development via the MAPK signaling.
    Mol Cell Biol. 2021 May 24. pii: MCB.00059-21. doi: 10.1128/MCB.00059.
    PubMed    
    Abstract available

  274. TIAN-ZHAO D, Yang Y, Xing-Xuan W, Yu-Xin C, et al
    Profiling of circular RNAs and circTPCN/miR-634/mTOR regulatory pathway in cervical cancer.
    Genomics. 2021 May 21. pii: S0888-7543(21)00199.
    PubMed    
    Abstract available

  275. JIANG D, Ren C, Yang L, Li F, et al
    Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
    J Obstet Gynaecol Res. 2021 May 24. doi: 10.1111/jog.14813.
    PubMed    
    Abstract available

  276. DONKERS H, McGrane J, Eleuteri A, Giamougiannis P, et al
    The impact of socioeconomic deprivation on mortality in cervical cancer patients in Cornwall (England).
    Eur J Cancer Care (Engl). 2021 May 24:e13463. doi: 10.1111/ecc.13463.
    PubMed    
    Abstract available

  277. VENKATAS J, Singh M
    Nanomedicine-mediated optimization of immunotherapeutic approaches in cervical cancer.
    Nanomedicine (Lond). 2021 May 24. doi: 10.2217/nnm-2021-0044.
    PubMed    
    Abstract available

  278. HE B, Chen W, Liu L, Hou Z, et al
    Prediction Models for Prognosis of Cervical Cancer: Systematic Review and Critical Appraisal.
    Front Public Health. 2021;9:654454.
    PubMed    
    Abstract available

  279. ZUCCHERATO LW, Machado CMT, Magalhaes WCS, Martins PR, et al
    Cervical Cancer Stem-Like Cell Transcriptome Profiles Predict Response to Chemoradiotherapy.
    Front Oncol. 2021;11:639339.
    PubMed    
    Abstract available

  280. TIAN X, Wang X, Cui Z, Liu J, et al
    A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer.
    Adv Sci (Weinh). 2021;8:2001978.
    PubMed    
    Abstract available

  281. FA J
    Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells.
    Oncol Lett. 2021;22:524.
    PubMed    
    Abstract available

  282. MUROFUSHI KN, Ishida T, Baba K, Kawakita K, et al
    Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy.
    J Contemp Brachytherapy. 2021;13:32-38.
    PubMed    
    Abstract available

  283. MUNKHTOGOO D, Nansalmaa E, Chung KP
    The relationships of health literacy, preferred involvement, and patient activation with perceived involvement in care among Mongolian patients with breast and cervical cancer.
    Patient Educ Couns. 2021 May 11. pii: S0738-3991(21)00339.
    PubMed    
    Abstract available

  284. TIAN Y, Luo Y, Wang J
    MicroRNA-425 induces apoptosis and suppresses migration and invasion of human cervical cancer cells by targeting RAB2B.
    Int J Immunopathol Pharmacol. 2021;35:20587384211016131.
    PubMed    
    Abstract available

  285. DOZIE UW, Elebari BL, Nwaokoro CJ, Iwuoha GN, et al
    Knowledge, attitude and perception on cervical cancer screening among women attending ante-natal clinic in Owerri west L.G.A, South-Eastern Nigeria: A cross-sectional study.
    Cancer Treat Res Commun. 2021;28:100392.
    PubMed    
    Abstract available

  286. OGORODNIITCHOUK O, Aunier J, Bousarsar A, Lahmamssi C, et al
    Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experience.
    Cancer Radiother. 2021 May 19. pii: S1278-3218(21)00074.
    PubMed    
    Abstract available

  287. CABEL L, Bonneau C, Bernard-Tessier A, Hequet D, et al
    HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer.
    ESMO Open. 2021;6:100154.
    PubMed    
    Abstract available

  288. MAZONAKIS M, Lyraraki E, Tolia M, Damilakis J, et al
    Risk for second bladder and rectal malignancies from cervical cancer irradiation.
    J Appl Clin Med Phys. 2021 May 21. doi: 10.1002/acm2.13274.
    PubMed    
    Abstract available

  289. ZHU Y, Lu M, Dai KJ, Liu C, et al
    Comparison Between 360 degrees 3-D Transvaginal Ultrasound and Magnetic Resonance Imaging for Assessment of Vaginal Invasion in Cervical Cancer: A Preliminary Report.
    Ultrasound Med Biol. 2021 May 18. pii: S0301-5629(21)00192.
    PubMed    
    Abstract available

  290. SALWA M, Al-Munim TA
    HPV Vaccination in Bangladesh: Ethical Views.
    Recent Results Cancer Res. 2021;218:31-37.
    PubMed    
    Abstract available

  291. LIU J, Wang RY, Wei BB, Liu J, et al
    [Clear Cell Carcinoma of Cervix in a 12-Year-Old Girl: A Case Report].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52:534-538.
    PubMed    
    Abstract available

  292. LI YX, Luo HX, Wang W, Wang Z, et al
    Diagnostic accuracy of novel folate receptor-mediated staining solution detection (FRD) for CIN2+: A systematic review and meta analysis.
    Medicine (Baltimore). 2021;100:e26004.
    PubMed    
    Abstract available

  293. CAUSIN RL, da Silva LS, Evangelista AF, Leal LF, et al
    MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
    Biomed Res Int. 2021;2021:6650966.
    PubMed    
    Abstract available

  294. BJERKE RD, Laake I, Feiring B, Aamodt G, et al
    Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway.
    BMC Public Health. 2021;21:854.
    PubMed    
    Abstract available

  295. WIJAYANTI KE, Schutze H, MacPhail C, Braunack-Mayer A, et al
    Parents' knowledge, beliefs, acceptance and uptake of the HPV vaccine in members of The Association of Southeast Asian Nations (ASEAN): A systematic review of quantitative and qualitative studies.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00342.
    PubMed    
    Abstract available

  296. BROWN DR, Joura EA, Yen GP, Kothari S, et al
    Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence.
    Vaccine. 2021 Mar 17. pii: S0264-410X(20)31564.
    PubMed    
    Abstract available

  297. ESFANDYARI S, Elkafas H, Chugh RM, Park HS, et al
    Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  298. CHESSON HW, Laprise JF, Brisson M, Martin D, et al
    The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018.
    Sex Transm Dis. 2021;48:278-284.
    PubMed    
    Abstract available

  299. LEWIS RM, Laprise JF, Gargano JW, Unger ER, et al
    Estimated prevalence and incidence of disease-associated HPV types among 15-59-year-olds in the United States.
    Sex Transm Dis. 2021 Jan 23. pii: 00007435-900000000-97766.
    PubMed    
    Abstract available

  300. ARSHAD MA, Gitau S, Tam H, Park WE, et al
    Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography.
    Eur J Nucl Med Mol Imaging. 2021;48:2009-2023.
    PubMed    
    Abstract available

  301. LI J, Sun XF, Shen Y, Yang Q, et al
    Elevated Expression of T-Cell Immunoglobulin and Mucin Domain 3 on T Cells from Peripheral Blood in Patients with Cervical Carcinoma.
    Gynecol Obstet Invest. 2021;86.
    PubMed    
    Abstract available

  302. ASTI L, Hopley C, Avelis C, Bartsch SM, et al
    The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually.
    Sex Transm Dis. 2021;48:370-380.
    PubMed    
    Abstract available

  303. MALAMBO N
    "Not from home": Cancer screening avoidance and the safety of distance in Eswatini.
    Soc Sci Med. 2021;268:113440.
    PubMed    
    Abstract available

  304. SOHN AH, Chalermchockcharoenkit A, Teeraananchai S, Hansudewechakul R, et al
    Increased Burden of Concordant and Sequential Anogenital Human Papillomavirus Infections Among Asian Young Adult Women With Perinatally Acquired HIV Compared With HIV-Negative Peers.
    Sex Transm Dis. 2021;48:200-205.
    PubMed    
    Abstract available

  305. MREMI A, Linde DS, Mchome B, Mlay J, et al
    Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
    Acta Obstet Gynecol Scand. 2021;100:802-810.
    PubMed    
    Abstract available

  306. SWAI P, Kjaer SK, Mchome B, Manongi R, et al
    The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
    Acta Obstet Gynecol Scand. 2021;100:775-785.
    PubMed    
    Abstract available

  307. KATANGA J, Kjaer SK, Manongi R, Pembe AB, et al
    Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania.
    Acta Obstet Gynecol Scand. 2021;100:786-793.
    PubMed    
    Abstract available

  308. PORS J, Segura S, Chiu DS, Almadani N, et al
    Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.
    Am J Surg Pathol. 2020 Nov 5. doi: 10.1097/PAS.0000000000001612.
    PubMed    
    Abstract available

  309. KREGTING LM, Kaljouw S, de Jonge L, Jansen EEL, et al
    Effects of cancer screening restart strategies after COVID-19 disruption.
    Br J Cancer. 2021;124:1516-1523.
    PubMed    
    Abstract available

  310. GARCIA-SOTO AE, McKenzie ND, Whicker ME, Pearson JM, et al
    Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
    Cancer. 2021 May 1. doi: 10.1002/cncr.33449.
    PubMed    
    Abstract available

  311. WENZEL HHB, Bekkers RLM, Lemmens VEPP, Van der Aa MA, et al
    No improvement in survival of older women with cervical cancer-A nationwide study.
    Eur J Cancer. 2021;151:159-167.
    PubMed    
    Abstract available

  312. MANCEBO G, Miralpeix E, Sole-Sedeno JM, Tio G, et al
    Influence of age on treatment and prognosis of invasive cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2021;262:68-72.
    PubMed    
    Abstract available

  313. MOHR S, Gygax LN, Imboden S, Mueller MD, et al
    Screening for HPV and dysplasia in transgender patients: Do we need it?
    Eur J Obstet Gynecol Reprod Biol. 2021;260:177-182.
    PubMed    
    Abstract available

  314. O'NEILL D, Pounds R, Scully N, Marriott N, et al
    The impact on obstetric outcomes following complete amputation of the cervix uteri in fertility preservation surgery for cervical neoplasm.
    Eur J Obstet Gynecol Reprod Biol. 2021;260:171-176.
    PubMed    
    Abstract available

  315. CHO WK, Park W, Kim YS, Kang HC, et al
    Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03).
    Eur J Obstet Gynecol Reprod Biol. 2021;258:396-400.
    PubMed    
    Abstract available

  316. LEESON S, Alalade R, Singh N, Nieminen P, et al
    Options for triage and implications for colposcopists within European HPV-based cervical screening programmes.
    Eur J Obstet Gynecol Reprod Biol. 2021;258:332-342.
    PubMed    
    Abstract available

  317. MULHOLLAND R, Yousef HMSA, Laing M, Gupta R, et al
    Comparison of women with possible endocervical and non-cervical glandular neoplasms detected in liquid-based cervical cytology- incidence, clinical characteristics and outcomes: A cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2021;257:100-105.
    PubMed    
    Abstract available

  318. LIMA PSV, Mantoani PTS, Murta EFC, Nomelini RS, et al
    Laboratory parameters as predictors of prognosis in uterine cervical neoplasia.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:391-396.
    PubMed    
    Abstract available

  319. REDMAN CWE, Kesic V, Cruickshank ME, Gultekin M, et al
    European consensus statement on essential colposcopy.
    Eur J Obstet Gynecol Reprod Biol. 2021;256:57-62.
    PubMed    
    Abstract available

  320. GRIGORE M, Cruickshank ME, Nieminen P, Tjalma W, et al
    National guidelines for management of cervical squamous intraepithelial lesion: A survey of European Federation for colposcopy members.
    Eur J Obstet Gynecol Reprod Biol. 2021;256:46-50.
    PubMed    
    Abstract available

  321. FONNES T, Telle IO, Forsse D, Falck R, et al
    Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers.
    Eur J Obstet Gynecol Reprod Biol. 2020;256:25-31.
    PubMed    
    Abstract available

  322. WANG Y, Peng Y, Lin Z, Yao T, et al
    The safety and effectiveness of preserving the ascending uterine artery in a modified fertility-sparing abdominal radical trachelectomy.
    Eur J Obstet Gynecol Reprod Biol. 2020;252:193-197.
    PubMed    
    Abstract available

  323. DILLEY S, Huh W, Blechter B, Rositch AF, et al
    It's time to re-evaluate cervical Cancer screening after age 65.
    Gynecol Oncol. 2021 Apr 26. pii: S0090-8258(21)00347.
    PubMed    
    Abstract available

  324. MATSUO K, Mandelbaum RS, Klar M, Ciesielski KM, et al
    Decreasing utilization of minimally invasive hysterectomy for cervical cancer in the United States.
    Gynecol Oncol. 2021 May 12. pii: S0090-8258(21)00364.
    PubMed    
    Abstract available

  325. RAMACHANDRAN D, Wang Y, Schurmann P, Hulse F, et al
    Association of genomic variants at PAX8 and PBX2 with cervical cancer risk.
    Int J Cancer. 2021 Apr 27. doi: 10.1002/ijc.33614.
    PubMed    
    Abstract available

  326. DEREJE N, Addissie A, Worku A, Gebremariam A, et al
    Association between waiting time for radiotherapy initiation and disease progression among women with cervical cancer in Addis Ababa, Ethiopia.
    Int J Cancer. 2021 May 17. doi: 10.1002/ijc.33689.
    PubMed    
    Abstract available

  327. DORJI T, Tshomo U, Gyamtsho S, Tamang ST, et al
    Gender-neutral HPV elimination, cervical cancer screening, and treatment: Experience from Bhutan.
    Int J Gynaecol Obstet. 2021 Apr 30. doi: 10.1002/ijgo.13728.
    PubMed    
    Abstract available

  328. SOFTELAND S, Sebitloane MH, Taylor M, Roald BB, et al
    A systematic review of handheld tools in lieu of colposcopy for cervical neoplasia and female genital schistosomiasis.
    Int J Gynaecol Obstet. 2021;153:190-199.
    PubMed    
    Abstract available

  329. GOMEZ RODRIGO S, Calderon J, Dionisi JN, Santi A, et al
    Cervical cancer in pregnancy at various gestational ages.
    Int J Gynecol Cancer. 2021;31:784-788.
    PubMed    


  330. KUMAR D, Miriyala R, Rai B, Bansal P, et al
    Impact of three-dimensional chemoradiation on pelvic bone mineral density, low back pain, and disability in cervical cancer: a prospective study.
    Int J Gynecol Cancer. 2021 May 11. pii: ijgc-2020-002290.
    PubMed    
    Abstract available

  331. WRIGHT JD
    Minimal risk for minimally invasive hysterectomy for stage IA cervical cancer?
    Int J Gynecol Cancer. 2021 May 10. pii: ijgc-2021-002733.
    PubMed    


  332. MATSUO K, Nusbaum DJ, Matsuzaki S, Klar M, et al
    Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States.
    Int J Gynecol Cancer. 2021 May 20. pii: ijgc-2021-002655.
    PubMed    
    Abstract available

  333. MANZOUR N, Vazquez-Vicente D, Carriles I, Boria F, et al
    Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
    Int J Gynecol Cancer. 2021 May 24. pii: ijgc-2021-002592.
    PubMed    


  334. STURDZA AE, Poetter R, Kossmeier M, Kirchheiner K, et al
    Nomogram predicting overall survival in locally advanced cervical cancer patients treated by radio-chemotherapy including image guided brachytherapy: a Retro-EMBRACE study.
    Int J Radiat Oncol Biol Phys. 2021 Apr 28. pii: S0360-3016(21)00404.
    PubMed    
    Abstract available

  335. DEZEN T, Rossini RR, Spadin MD, Da Cunha Andrade CEM, et al
    Accuracy of MRI for diagnosing pelvic and paraaortic lymph node metastasis in cervical cancer.
    Oncol Rep. 2021;45.
    PubMed    
    Abstract available

  336. MAHANTSHETTY U, Poetter R, Beriwal S, Grover S, et al
    IBS-GEC ESTRO-ABS Recommendations for CT Based Contouring in Image Guided Adaptive Brachytherapy for Cervical cancer.
    Radiother Oncol. 2021 May 17. pii: S0167-8140(21)06248.
    PubMed    
    Abstract available

  337. YUCE SARI S, Yigit E, Gultekin M, Yildiz F, et al
    In regard to Spampinato et al.
    Radiother Oncol. 2021;158:321-322.
    PubMed    


  338. SPAMPINATO S, Fokdal LU, Potter R, Haie-Meder C, et al
    Response to Yuce Sari et al.
    Radiother Oncol. 2021;158:323-324.
    PubMed    


  339. FENG Y, Wang Y, Xie Y, Wu S, et al
    Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    BMC Cancer. 2021;21:450.
    PubMed    
    Abstract available

  340. LI W, Xiong L, Zhu Q, Lu H, et al
    Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
    BMC Cancer. 2021;21:484.
    PubMed    
    Abstract available

  341. SHARMIN S, Zohura FT, Islam MS, Shimonty A, et al
    Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
    BMC Cancer. 2021;21:289.
    PubMed    
    Abstract available

  342. GAETE S, Auguste A, Bhakkan B, Peruvien J, et al
    Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe.
    BMC Cancer. 2021;21:281.
    PubMed    
    Abstract available

  343. SATO A, Matsubayashi K, Morishima T, Nakata K, et al
    Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
    BMC Cancer. 2021;21:264.
    PubMed    
    Abstract available

  344. CHEN HH, Meng WY, Li RZ, Wang QY, et al
    Potential prognostic factors in progression-free survival for patients with cervical cancer.
    BMC Cancer. 2021;21:531.
    PubMed    
    Abstract available

  345. DEL MORAL-HERNANDEZ O, Hernandez-Sotelo D, Alarcon-Romero LDC, Mendoza-Catalan MA, et al
    TOP2A/MCM2, p16(INK4a), and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
    BMC Cancer. 2021;21:39.
    PubMed    
    Abstract available

  346. ZHANG SW, Luo RZ, Sun XY, Yang X, et al
    Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.
    BMC Cancer. 2021;21:332.
    PubMed    
    Abstract available

  347. DENG ZM, Dai FF, Zhou Q, Cheng YX, et al
    Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis.
    BMC Cancer. 2021;21:583.
    PubMed    
    Abstract available

  348. PENG L, Hayatullah G, Zhou H, Chang S, et al
    Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
    PLoS One. 2021;16:e0249374.
    PubMed    
    Abstract available

  349. VIEIRA MA, de Araujo RLC, da Cunha Andrade CEM, Schmidt RL, et al
    A randomized clinical trial of a new anti-cervical stenosis device after conization by loop electrosurgical excision.
    PLoS One. 2021;16:e0242067.
    PubMed    
    Abstract available

  350. SONGANE M, Grossmann V
    The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value.
    PLoS One. 2021;16:e0244722.
    PubMed    
    Abstract available

  351. VALE DB, Silva MT, Discacciati MG, Polegatto I, et al
    Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country.
    PLoS One. 2021;16:e0251688.
    PubMed    
    Abstract available

  352. SUZUKI S, Hayata E, Hoshi SI, Sekizawa A, et al
    Current status of cervical cytology during pregnancy in Japan.
    PLoS One. 2021;16:e0245282.
    PubMed    
    Abstract available

  353. LIU H, Xu J, Yang Y, Wang X, et al
    Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;